Cargando…

Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments

OBJECTIVE: Evaluate differences in TB outcomes among different provider types in Chicago, IL. METHODS: We retrospectively reviewed all TB cases reported to the Chicago Department of Public Health (CDPH) from 2008 through 2011. Provider type was stratified into three groups: public, public-private, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Reid, Jones, Joshua D., Shah, Neha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061361/
https://www.ncbi.nlm.nih.gov/pubmed/27732650
http://dx.doi.org/10.1371/journal.pone.0164162
_version_ 1782459592767176704
author Fletcher, Reid
Jones, Joshua D.
Shah, Neha S.
author_facet Fletcher, Reid
Jones, Joshua D.
Shah, Neha S.
author_sort Fletcher, Reid
collection PubMed
description OBJECTIVE: Evaluate differences in TB outcomes among different provider types in Chicago, IL. METHODS: We retrospectively reviewed all TB cases reported to the Chicago Department of Public Health (CDPH) from 2008 through 2011. Provider type was stratified into three groups: public, public-private, and private providers. Multivariate regression was used to evaluate treatment duration and time to sputum culture conversion. A Cox proportional hazard model was used to assess treatment completion. RESULTS: Of 703 cases, 203 (28.9%), 314 (44.7%), and 186 (26.5%) were treated by public, public-private and private providers, respectively. Adjusted regression showed private provider patients had a 48-day (95% CI 22.0–74.3) increase in treatment duration and a 30-day (95% C.I. 9.5–51.1) increase in time to sputum culture conversion. Cox model showed increased risk of remaining on treatment was associated with extra-pulmonary TB (aHR 0.78, 95% C.I. 0.62–0.98), being foreign-born (aHR 0.74, 95% C.I. 0.58–0.95), and any drug resistance (aHR 0.59, 95% C.I. 0.46–0.76). There were no differences in outcomes between public and public-private providers. CONCLUSION: Patients treated solely in the private sector had prolonged time to sputum culture conversion and treatment duration which lead to increased cost for treatment, prolonged infectiousness, potential for transmission, and the possibility for increased medication side effects.
format Online
Article
Text
id pubmed-5061361
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50613612016-10-27 Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments Fletcher, Reid Jones, Joshua D. Shah, Neha S. PLoS One Research Article OBJECTIVE: Evaluate differences in TB outcomes among different provider types in Chicago, IL. METHODS: We retrospectively reviewed all TB cases reported to the Chicago Department of Public Health (CDPH) from 2008 through 2011. Provider type was stratified into three groups: public, public-private, and private providers. Multivariate regression was used to evaluate treatment duration and time to sputum culture conversion. A Cox proportional hazard model was used to assess treatment completion. RESULTS: Of 703 cases, 203 (28.9%), 314 (44.7%), and 186 (26.5%) were treated by public, public-private and private providers, respectively. Adjusted regression showed private provider patients had a 48-day (95% CI 22.0–74.3) increase in treatment duration and a 30-day (95% C.I. 9.5–51.1) increase in time to sputum culture conversion. Cox model showed increased risk of remaining on treatment was associated with extra-pulmonary TB (aHR 0.78, 95% C.I. 0.62–0.98), being foreign-born (aHR 0.74, 95% C.I. 0.58–0.95), and any drug resistance (aHR 0.59, 95% C.I. 0.46–0.76). There were no differences in outcomes between public and public-private providers. CONCLUSION: Patients treated solely in the private sector had prolonged time to sputum culture conversion and treatment duration which lead to increased cost for treatment, prolonged infectiousness, potential for transmission, and the possibility for increased medication side effects. Public Library of Science 2016-10-12 /pmc/articles/PMC5061361/ /pubmed/27732650 http://dx.doi.org/10.1371/journal.pone.0164162 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Fletcher, Reid
Jones, Joshua D.
Shah, Neha S.
Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title_full Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title_fullStr Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title_full_unstemmed Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title_short Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments
title_sort treatment of active tuberculosis in chicago, 2008-2011: the role of public health departments
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061361/
https://www.ncbi.nlm.nih.gov/pubmed/27732650
http://dx.doi.org/10.1371/journal.pone.0164162
work_keys_str_mv AT fletcherreid treatmentofactivetuberculosisinchicago20082011theroleofpublichealthdepartments
AT jonesjoshuad treatmentofactivetuberculosisinchicago20082011theroleofpublichealthdepartments
AT shahnehas treatmentofactivetuberculosisinchicago20082011theroleofpublichealthdepartments